Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study

Table 3 Incidence rate (IR) of cardiovascular disease events^a (CVDe) among persons living with HIV exposed to abacavir for various durations

Duration of exposure to abacavir (months)	Person-years	No. of CVDe	Incidence rate per 1000 people (95% CI)
Never exposed	98,857	561	5.68 (5.22, 6.16)
1–6	4757	51	10.72 (8.15, 14.11)
7–12	3125	31	9.92 (6.98, 14.11)
13–18	2208	25	11.32 (7.65, 16.76)
19–24	1663	18	10.82 (6.82, 17.18)
>25	3860	28	7.25 (5.01, 10.51)

ISSN: 1471-2334